Sectors

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The CNS disease drug developer has raised funding in a GV-backed round just four months after it emerged from UT Southwestern with $30m.

Osage University Partners backed a round for Aerovate Therapeutics that will go to testing an inhaled version of the latter's pulmonary disease therapy.

The $250m investment made by Sony in July was rolled into the Fortnite developer's latest round, which valued it at $17.3bn post-money.

Osage University Partners has returned to bring the big urban transit data analytics company's funding total to more than $40m.

GV and Decibel co-led the round having previously backed the U-M networking cybersecurity company alongside Greylock Partners in 2016.

Wenge Tech, a CAS-owned data analytics business targeting media applications, has attracted Cash Holdings and CAS Star for its latest round.

Gene therapy developer Freeline Therapeutics priced an upsized offering at the top of its range following $275m in funding from investors including Novo.

Koch Industries and CK Hutchison both participated in a series D round that pushed the medical imaging system developer's total funding to more than $124m.

The CNS disease drug developer has raised funding in a GV-backed round just four months after it emerged from stealth with $30m.

The mental healthcare app developer boosted its overall funding to $120m in a round that included Cigna Ventures and Kaiser Permanente Ventures.